The world is currently experiencing a huge challenge which has affected all the industries and markets. Few markets have experienced a high growth in their demand while others have faced a downfall. The extent of growth or drop in the market statistics of different industries by COVID 19 plays an important role in how the future of businesses will shape up in the near future. We at Value Market Research provide you with an impact analysis of COVID 19 on this market with its latest update in the purchased version of the report.
Global AAV Contract Development And Manufacturing Organizations Market Report By Workflow (Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting), Downstream Processing (Purification, Fill Finish)), By Culture Type (Adherent Culture, Suspension Culture), By Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical & Pharmaceutical Discovery, Biomedical Research), By End-user (Pharmaceutical & Biopharmaceutical Companies, Academic & Research Institutes) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028
ID:VMR11220635
March 2023
Report Formats: Electronic (PDF), MS EXCEL
The global demand for AAV Contract Development And Manufacturing Organizations Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
AAV (adeno-associated virus) Contract Development and Manufacturing Organizations (CDMOs) are companies that specialize in the development, manufacturing, and testing of AAV-based gene therapies. AAV is a small, non-pathogenic virus that is commonly used as a vector for gene delivery in gene therapy. AAV CDMOs work with clients to design and optimize AAV vectors for specific therapeutic applications. They also provide services for the production of AAV vectors, including the development of cell lines, optimization of vector production processes, and purification and characterization of the final product. In addition, AAV CDMOs conduct rigorous testing of the AAV vectors to ensure safety and efficacy, including tests for potency, purity, sterility, and identity.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of aav contract development and manufacturing organizations. The growth and trends of aav contract development and manufacturing organizations industry provide a holistic approach to this study.
By Workflow
By Culture Type
By Application
By End-User
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the aav contract development and manufacturing organizations market include Thermo Fischer Scientific Inc., Creative Biogene, Catalent Inc., Charles River Laboratories International Inc., Danaher (Aldevron), Forge Biologics, Genezen, ViroCell Biologics, Merck KGaA, VIRALGEN, Biovian Oy, Esco Lifesciences (Esco Aster Pte. Ltd.), GenScript ProBio, Porton Advanced Solution Ltd, Ask Bio, Showa Denko, Takara Bio Inc., ABL Manufacturing, Oxford Biomedica, Belief Biomed Inc., Beijing Anlong Biomedicine Co. Ltd, Forecyte Bio Limited, Gene Pharma Inc., Skyline Therapeutics, TFBS Bioscience Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
AAV (adeno-associated virus) Contract Development and Manufacturing Organizations (CDMOs) are companies that specialize in the development, manufacturing, and testing of AAV-based gene therapies. AAV is a small, non-pathogenic virus that is commonly used as a vector for gene delivery in gene therapy. AAV CDMOs work with clients to design and optimize AAV vectors for specific therapeutic applications. They also provide services for the production of AAV vectors, including the development of cell lines, optimization of vector production processes, and purification and characterization of the final product. In addition, AAV CDMOs conduct rigorous testing of the AAV vectors to ensure safety and efficacy, including tests for potency, purity, sterility, and identity.
Market Dynamics
The market for gene therapies is expanding rapidly as more gene therapy products are approved for clinical use. AAV vectors are a popular choice for gene therapy delivery, and the increasing demand for gene therapies is driving growth in the AAV CDMO market. Advances in AAV vector technology have led to improved vector production processes, increased transduction efficiency, and reduced immune responses. These advances have made AAV vectors more attractive for gene therapy applications and have increased the demand for AAV CDMO services. The availability of funding for gene therapy research has increased significantly in recent years, with government agencies, private investors, and non-profit organizations all contributing to the gene therapy market growth. This funding is driving the development of new gene therapies, which in turn is increasing demand for AAV CDMO services. Regulatory agencies such as the FDA have shown support for the development of gene therapies and have implemented expedited approval pathways for gene therapy products. This regulatory support is helping to drive growth in the gene therapy market, including the AAV CDMO market. Many biotech and pharma companies are choosing to outsource their gene therapy manufacturing to specialized CDMOs rather than investing in expensive in-house facilities. This trend is increasing demand for AAV CDMO services as these companies seek out experienced partners to help them develop and manufacture their gene therapy products.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of aav contract development and manufacturing organizations. The growth and trends of aav contract development and manufacturing organizations industry provide a holistic approach to this study.
Market Segmentation
This section of the aav contract development and manufacturing organizations market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.By Workflow
- Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting)
- Downstream Processing (Purification, Fill Finish)
By Culture Type
- Adherent Culture
- Suspension Culture
By Application
- Cell & Gene Therapy Development
- Vaccine Development
- Biopharmaceutical & Pharmaceutical Discovery
- Biomedical Research
By End-User
- Pharmaceutical & Biopharmaceutical Companies
- Academic & Research Institutes
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the AAV Contract Development And Manufacturing Organizations market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.Global AAV Contract Development And Manufacturing Organizations Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the aav contract development and manufacturing organizations market include Thermo Fischer Scientific Inc., Creative Biogene, Catalent Inc., Charles River Laboratories International Inc., Danaher (Aldevron), Forge Biologics, Genezen, ViroCell Biologics, Merck KGaA, VIRALGEN, Biovian Oy, Esco Lifesciences (Esco Aster Pte. Ltd.), GenScript ProBio, Porton Advanced Solution Ltd, Ask Bio, Showa Denko, Takara Bio Inc., ABL Manufacturing, Oxford Biomedica, Belief Biomed Inc., Beijing Anlong Biomedicine Co. Ltd, Forecyte Bio Limited, Gene Pharma Inc., Skyline Therapeutics, TFBS Bioscience Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Workflow
3.7.2 Market Attractiveness Analysis By Culture Type
3.7.3 Market Attractiveness Analysis By Application
3.7.4 Market Attractiveness Analysis By End-user
3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY WORKFLOW
6.1 Overview by Workflow
6.2 Historical and Forecast Data
6.3 Analysis by Workflow
6.4 Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting) Historic and Forecast Sales by Regions
6.5 Downstream Processing (Purification, Fill Finish) Historic and Forecast Sales by Regions
7 . GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY CULTURE TYPE
7.1 Overview by Culture Type
7.2 Historical and Forecast Data
7.3 Analysis by Culture Type
7.4 Adherent Culture Historic and Forecast Sales by Regions
7.5 Suspension Culture Historic and Forecast Sales by Regions
8 . GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY APPLICATION
8.1 Overview by Application
8.2 Historical and Forecast Data
8.3 Analysis by Application
8.4 Cell & Gene Therapy Development Historic and Forecast Sales by Regions
8.5 Vaccine Development Historic and Forecast Sales by Regions
8.6 Biopharmaceutical & Pharmaceutical Discovery Historic and Forecast Sales by Regions
8.7 Biomedical Research Historic and Forecast Sales by Regions
9 . GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY END-USER
9.1 Overview by End-user
9.2 Historical and Forecast Data
9.3 Analysis by End-user
9.4 Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales by Regions
9.5 Academic & Research Institutes Historic and Forecast Sales by Regions
10 . GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY GEOGRAPHY
10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
10.3.1. Overview, Historic and Forecast Sales Analysis
10.3.2. North America By Segment Sales Analysis
10.3.3. North America By Country Sales Analysis
10.3.4. United State Sales Analysis
10.3.5. Canada Sales Analysis
10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
10.4.1. Overview, Historic and Forecast Sales Analysis
10.4.2. Europe by Segment Sales Analysis
10.4.3. Europe by Country Sales Analysis
10.4.4. United Kingdom Sales Analysis
10.4.5. France Sales Analysis
10.4.6. Germany Sales Analysis
10.4.7. Italy Sales Analysis
10.4.8. Russia Sales Analysis
10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
10.5.1. Overview, Historic and Forecast Sales Analysis
10.5.2. Asia Pacific by Segment Sales Analysis
10.5.3. Asia Pacific by Country Sales Analysis
10.5.4. China Sales Analysis
10.5.5. India Sales Analysis
10.5.6. Japan Sales Analysis
10.5.7. South Korea Sales Analysis
10.5.8. Australia Sales Analysis
10.5.9. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
10.6.1. Overview, Historic and Forecast Sales Analysis
10.6.2. Latin America by Segment Sales Analysis
10.6.3. Latin America by Country Sales Analysis
10.6.4. Brazil Sales Analysis
10.6.5. Argentina Sales Analysis
10.6.6. Peru Sales Analysis
10.6.7. Chile Sales Analysis
10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
10.7.1. Overview, Historic and Forecast Sales Analysis
10.7.2. Middle East & Africa by Segment Sales Analysis
10.7.3. Middle East & Africa by Country Sales Analysis
10.7.4. Saudi Arabia Sales Analysis
10.7.5. UAE Sales Analysis
10.7.6. Israel Sales Analysis
10.7.7. South Africa Sales Analysis
10.7.8. Rest Of Middle East And Africa Sales Analysis
11 . COMPETITIVE LANDSCAPE OF THE AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS COMPANIES
11.1. Aav Contract Development And Manufacturing Organizations Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments
12 . COMPANY PROFILES OF AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS INDUSTRY
12.1. Top Company Share Analysis
12.2. Market Concentration Rate
12.3. Thermo Fischer Scientific Inc.
12.3.1. Company Overview
12.3.2. Company Revenue
12.3.3. Products
12.3.4. Recent Developments
12.4. Creative Biogene
12.4.1. Company Overview
12.4.2. Company Revenue
12.4.3. Products
12.4.4. Recent Developments
12.5. Catalent Inc.
12.5.1. Company Overview
12.5.2. Company Revenue
12.5.3. Products
12.5.4. Recent Developments
12.6. Charles River Laboratories International Inc.
12.6.1. Company Overview
12.6.2. Company Revenue
12.6.3. Products
12.6.4. Recent Developments
12.7. Danaher (Aldevron)
12.7.1. Company Overview
12.7.2. Company Revenue
12.7.3. Products
12.7.4. Recent Developments
12.8. Forge Biologics
12.8.1. Company Overview
12.8.2. Company Revenue
12.8.3. Products
12.8.4. Recent Developments
12.9. Genezen
12.9.1. Company Overview
12.9.2. Company Revenue
12.9.3. Products
12.9.4. Recent Developments
12.10. ViroCell Biologics
12.10.1. Company Overview
12.10.2. Company Revenue
12.10.3. Products
12.10.4. Recent Developments
12.11. Merck KGaA
12.11.1. Company Overview
12.11.2. Company Revenue
12.11.3. Products
12.11.4. Recent Developments
12.12. VIRALGEN
12.12.1. Company Overview
12.12.2. Company Revenue
12.12.3. Products
12.12.4. Recent Developments
12.13. Biovian Oy
12.13.1. Company Overview
12.13.2. Company Revenue
12.13.3. Products
12.13.4. Recent Developments
12.14. Esco Lifesciences (Esco Aster Pte. Ltd.)
12.14.1. Company Overview
12.14.2. Company Revenue
12.14.3. Products
12.14.4. Recent Developments
12.15. GenScript ProBio
12.15.1. Company Overview
12.15.2. Company Revenue
12.15.3. Products
12.15.4. Recent Developments
12.16. Porton Advanced Solution Ltd
12.16.1. Company Overview
12.16.2. Company Revenue
12.16.3. Products
12.16.4. Recent Developments
12.17. Ask Bio
12.17.1. Company Overview
12.17.2. Company Revenue
12.17.3. Products
12.17.4. Recent Developments
12.18. Showa Denko
12.18.1. Company Overview
12.18.2. Company Revenue
12.18.3. Products
12.18.4. Recent Developments
12.19. Takara Bio Inc.
12.19.1. Company Overview
12.19.2. Company Revenue
12.19.3. Products
12.19.4. Recent Developments
12.20. ABL Manufacturing
12.20.1. Company Overview
12.20.2. Company Revenue
12.20.3. Products
12.20.4. Recent Developments
12.21. Oxford Biomedica
12.21.1. Company Overview
12.21.2. Company Revenue
12.21.3. Products
12.21.4. Recent Developments
12.22. Belief Biomed Inc.
12.22.1. Company Overview
12.22.2. Company Revenue
12.22.3. Products
12.22.4. Recent Developments
12.23. Beijing Anlong Biomedicine Co. Ltd
12.23.1. Company Overview
12.23.2. Company Revenue
12.23.3. Products
12.23.4. Recent Developments
12.24. Forecyte Bio Limited
12.24.1. Company Overview
12.24.2. Company Revenue
12.24.3. Products
12.24.4. Recent Developments
12.25. Gene Pharma Inc.
12.25.1. Company Overview
12.25.2. Company Revenue
12.25.3. Products
12.25.4. Recent Developments
12.26. Skyline Therapeutics
12.26.1. Company Overview
12.26.2. Company Revenue
12.26.3. Products
12.26.4. Recent Developments
12.27. TFBS Bioscience Inc.
12.27.1. Company Overview
12.27.2. Company Revenue
12.27.3. Products
12.27.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Workflow (USD MN)
- Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting) Market Sales by Geography (USD MN)
- Downstream Processing (Purification, Fill Finish) Market Sales by Geography (USD MN)
- Analysis Market by Culture Type (USD MN)
- Adherent Culture Market Sales by Geography (USD MN)
- Suspension Culture Market Sales by Geography (USD MN)
- Analysis by Application (USD MN)
- Cell & Gene Therapy Development Market Sales by Geography (USD MN)
- Vaccine Development Market Sales by Geography (USD MN)
- Biopharmaceutical & Pharmaceutical Discovery Market Sales by Geography (USD MN)
- Biomedical Research Market Sales by Geography (USD MN)
- Analysis by End-user (USD MN)
- Pharmaceutical & Biopharmaceutical Companies Market Sales by Geography (USD MN)
- Academic & Research Institutes Market Sales by Geography (USD MN)
- Global Aav Contract Development And Manufacturing Organizations Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Aav Contract Development And Manufacturing Organizations Report
- Market Research Process
- Market Research Methodology
- Global Aav Contract Development And Manufacturing Organizations Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Workflow
- Market Attractiveness Analysis by Culture Type
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by End-user
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Workflow (USD MN)
- Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting) Market Sales by Geography (USD MN)
- Downstream Processing (Purification, Fill Finish) Market Sales by Geography (USD MN)
- Global Market Analysis by Culture Type (USD MN)
- Adherent Culture Market Sales by Geography (USD MN)
- Suspension Culture Market Sales by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Cell & Gene Therapy Development Market Sales by Geography (USD MN)
- Vaccine Development Market Sales by Geography (USD MN)
- Biopharmaceutical & Pharmaceutical Discovery Market Sales by Geography (USD MN)
- Biomedical Research Market Sales by Geography (USD MN)
- Global Market Analysis by End-user (USD MN)
- Pharmaceutical & Biopharmaceutical Companies Market Sales by Geography (USD MN)
- Academic & Research Institutes Market Sales by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Top Company Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Related Categories
Healthcare
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments